Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 81 | 2025 | 280 | 17.250 |
Why?
|
| Knee Joint | 53 | 2025 | 173 | 7.210 |
Why?
|
| Osteoarthritis | 10 | 2024 | 104 | 3.840 |
Why?
|
| Disease Progression | 33 | 2024 | 2206 | 2.200 |
Why?
|
| Radiography | 25 | 2025 | 762 | 2.040 |
Why?
|
| Tibia | 14 | 2023 | 81 | 2.040 |
Why?
|
| Arthralgia | 9 | 2024 | 77 | 2.030 |
Why?
|
| Bone Density | 8 | 2018 | 363 | 1.670 |
Why?
|
| Running | 3 | 2018 | 32 | 1.630 |
Why?
|
| Cartilage, Articular | 13 | 2023 | 63 | 1.590 |
Why?
|
| Exercise | 7 | 2025 | 866 | 1.360 |
Why?
|
| Bone Marrow | 12 | 2020 | 314 | 1.290 |
Why?
|
| Magnetic Resonance Imaging | 39 | 2023 | 3917 | 1.200 |
Why?
|
| Pain | 10 | 2024 | 439 | 1.180 |
Why?
|
| Gardening | 2 | 2025 | 18 | 1.150 |
Why?
|
| Middle Aged | 70 | 2025 | 28883 | 1.100 |
Why?
|
| Aged | 58 | 2025 | 21255 | 1.070 |
Why?
|
| Knee Injuries | 9 | 2023 | 40 | 1.040 |
Why?
|
| Longitudinal Studies | 20 | 2023 | 1516 | 1.030 |
Why?
|
| Cross-Sectional Studies | 18 | 2025 | 3834 | 0.980 |
Why?
|
| Arthroplasty, Replacement, Knee | 7 | 2023 | 153 | 0.960 |
Why?
|
| Synovitis | 7 | 2022 | 24 | 0.910 |
Why?
|
| Pain Measurement | 13 | 2019 | 354 | 0.890 |
Why?
|
| Bicycling | 1 | 2024 | 35 | 0.830 |
Why?
|
| Exercise Therapy | 2 | 2024 | 175 | 0.820 |
Why?
|
| Weight-Bearing | 7 | 2016 | 44 | 0.820 |
Why?
|
| Resistance Training | 1 | 2023 | 26 | 0.810 |
Why?
|
| Walking | 5 | 2022 | 234 | 0.810 |
Why?
|
| Menisci, Tibial | 7 | 2023 | 41 | 0.800 |
Why?
|
| Humans | 102 | 2025 | 131604 | 0.770 |
Why?
|
| Male | 74 | 2025 | 65228 | 0.740 |
Why?
|
| Femur | 6 | 2023 | 74 | 0.740 |
Why?
|
| Methotrexate | 1 | 2024 | 342 | 0.730 |
Why?
|
| Female | 75 | 2025 | 71145 | 0.670 |
Why?
|
| Football | 1 | 2020 | 36 | 0.620 |
Why?
|
| Swimming | 1 | 2019 | 30 | 0.620 |
Why?
|
| Tibial Meniscus Injuries | 4 | 2019 | 34 | 0.590 |
Why?
|
| Chronic Pain | 1 | 2021 | 159 | 0.570 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 3094 | 0.560 |
Why?
|
| Cancellous Bone | 1 | 2018 | 8 | 0.550 |
Why?
|
| Physicians | 1 | 2024 | 634 | 0.520 |
Why?
|
| Bone Malalignment | 2 | 2016 | 4 | 0.510 |
Why?
|
| Logistic Models | 10 | 2025 | 1831 | 0.500 |
Why?
|
| Knee | 2 | 2015 | 21 | 0.490 |
Why?
|
| Osteoarthritis, Hip | 3 | 2023 | 62 | 0.470 |
Why?
|
| Absorptiometry, Photon | 6 | 2018 | 199 | 0.460 |
Why?
|
| Risk Factors | 23 | 2023 | 10959 | 0.460 |
Why?
|
| Motor Activity | 2 | 2015 | 507 | 0.450 |
Why?
|
| Bone Marrow Diseases | 3 | 2011 | 45 | 0.440 |
Why?
|
| Quality of Life | 1 | 2024 | 2113 | 0.430 |
Why?
|
| Hand Joints | 2 | 2024 | 6 | 0.410 |
Why?
|
| Pain Management | 3 | 2019 | 199 | 0.380 |
Why?
|
| Body Mass Index | 11 | 2020 | 1695 | 0.360 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2025 | 226 | 0.360 |
Why?
|
| Blood Pressure | 1 | 2017 | 1344 | 0.350 |
Why?
|
| Cartilage Diseases | 2 | 2022 | 17 | 0.340 |
Why?
|
| Analgesics | 2 | 2009 | 122 | 0.330 |
Why?
|
| Joint Instability | 2 | 2019 | 57 | 0.290 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17666 | 0.290 |
Why?
|
| Hypertension | 1 | 2017 | 1360 | 0.280 |
Why?
|
| Prospective Studies | 6 | 2023 | 6494 | 0.280 |
Why?
|
| Prevalence | 3 | 2025 | 2694 | 0.270 |
Why?
|
| Cohort Studies | 7 | 2024 | 5123 | 0.270 |
Why?
|
| United States | 10 | 2025 | 11800 | 0.270 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 4039 | 0.260 |
Why?
|
| Time Factors | 10 | 2019 | 6279 | 0.250 |
Why?
|
| Symptom Assessment | 2 | 2018 | 109 | 0.250 |
Why?
|
| Vasculitis | 1 | 2006 | 47 | 0.250 |
Why?
|
| Prognosis | 8 | 2025 | 4952 | 0.250 |
Why?
|
| Retroelements | 1 | 2025 | 43 | 0.240 |
Why?
|
| Biomechanical Phenomena | 3 | 2017 | 265 | 0.230 |
Why?
|
| Incidence | 6 | 2022 | 3347 | 0.230 |
Why?
|
| Life Style | 1 | 2008 | 444 | 0.230 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2025 | 148 | 0.230 |
Why?
|
| Patient Education as Topic | 2 | 2024 | 463 | 0.230 |
Why?
|
| Denmark | 1 | 2024 | 29 | 0.220 |
Why?
|
| Case-Control Studies | 10 | 2023 | 3454 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2025 | 256 | 0.220 |
Why?
|
| Papillomavirus Vaccines | 1 | 2025 | 111 | 0.210 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 248 | 0.210 |
Why?
|
| Clinical Clerkship | 1 | 2024 | 72 | 0.210 |
Why?
|
| Skin | 1 | 2006 | 553 | 0.200 |
Why?
|
| Radiology | 1 | 2024 | 126 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2019 | 3695 | 0.190 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 108 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2024 | 118 | 0.190 |
Why?
|
| Walking Speed | 2 | 2020 | 18 | 0.190 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 1387 | 0.190 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 418 | 0.180 |
Why?
|
| Adult | 11 | 2025 | 31702 | 0.180 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2019 | 11 | 0.170 |
Why?
|
| Linear Models | 3 | 2018 | 695 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2024 | 469 | 0.170 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 389 | 0.170 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 2986 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 501 | 0.160 |
Why?
|
| Vaccination | 1 | 2025 | 1040 | 0.160 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2021 | 100 | 0.160 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2019 | 1 | 0.150 |
Why?
|
| Ligaments, Articular | 1 | 2019 | 22 | 0.150 |
Why?
|
| Synovial Membrane | 1 | 2019 | 27 | 0.150 |
Why?
|
| Curriculum | 1 | 2024 | 783 | 0.150 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 5296 | 0.150 |
Why?
|
| Rheumatology | 1 | 2020 | 128 | 0.140 |
Why?
|
| Arthrography | 1 | 2018 | 6 | 0.140 |
Why?
|
| X-Rays | 1 | 2018 | 30 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 1989 | 0.140 |
Why?
|
| Sound | 1 | 2017 | 21 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2025 | 998 | 0.140 |
Why?
|
| Iodine | 1 | 2017 | 23 | 0.130 |
Why?
|
| Radiographic Image Enhancement | 1 | 2017 | 40 | 0.130 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2017 | 5 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2019 | 366 | 0.130 |
Why?
|
| Systole | 1 | 2017 | 197 | 0.130 |
Why?
|
| Meniscus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Homeostasis | 2 | 2018 | 713 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 221 | 0.120 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 16 | 0.120 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2007 | 39 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 470 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2019 | 495 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 17 | 0.120 |
Why?
|
| Mammography | 1 | 2016 | 131 | 0.110 |
Why?
|
| Venous Thrombosis | 2 | 2007 | 168 | 0.110 |
Why?
|
| Vitamin D | 2 | 2014 | 194 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 422 | 0.100 |
Why?
|
| Contrast Media | 1 | 2017 | 490 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2020 | 1235 | 0.100 |
Why?
|
| Age Factors | 5 | 2020 | 2872 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 85 | 0.100 |
Why?
|
| Glucose | 1 | 2018 | 848 | 0.100 |
Why?
|
| Young Adult | 3 | 2025 | 10094 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Cartilage | 1 | 2013 | 54 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 377 | 0.100 |
Why?
|
| Hand | 2 | 2024 | 98 | 0.100 |
Why?
|
| Disability Evaluation | 2 | 2015 | 197 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2017 | 1104 | 0.090 |
Why?
|
| Vitamins | 1 | 2013 | 115 | 0.090 |
Why?
|
| Phenotype | 1 | 2022 | 4516 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2120 | 0.090 |
Why?
|
| Body Weight | 1 | 2016 | 990 | 0.090 |
Why?
|
| Hyaline Cartilage | 1 | 2011 | 2 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2021 | 12964 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2011 | 29 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1686 | 0.080 |
Why?
|
| Orthotic Devices | 1 | 2009 | 20 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 902 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 47 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 52 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Weight Loss | 1 | 2012 | 529 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 76 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2007 | 41 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1255 | 0.060 |
Why?
|
| Cefazolin | 1 | 2006 | 20 | 0.060 |
Why?
|
| Arterioles | 1 | 2006 | 38 | 0.060 |
Why?
|
| Delphi Technique | 2 | 2023 | 262 | 0.060 |
Why?
|
| Osteosclerosis | 1 | 2006 | 11 | 0.060 |
Why?
|
| Glypicans | 1 | 2025 | 40 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 190 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 644 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2008 | 1234 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1258 | 0.050 |
Why?
|
| Self Report | 2 | 2020 | 558 | 0.050 |
Why?
|
| CpG Islands | 1 | 2025 | 337 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 34 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2016 | 84 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2024 | 124 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2648 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 223 | 0.050 |
Why?
|
| Teaching | 1 | 2024 | 195 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 231 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 283 | 0.050 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2022 | 8 | 0.050 |
Why?
|
| Counseling | 1 | 2024 | 237 | 0.050 |
Why?
|
| Observer Variation | 2 | 2014 | 319 | 0.050 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1617 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 1306 | 0.040 |
Why?
|
| Androstenes | 1 | 2021 | 8 | 0.040 |
Why?
|
| Diet | 1 | 2008 | 1121 | 0.040 |
Why?
|
| Phenylthiohydantoin | 1 | 2021 | 14 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6922 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 20931 | 0.040 |
Why?
|
| Taxoids | 1 | 2021 | 71 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2022 | 184 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 114 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 122 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 244 | 0.040 |
Why?
|
| Nitriles | 1 | 2021 | 165 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 749 | 0.040 |
Why?
|
| London | 1 | 2020 | 15 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 565 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1453 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2390 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2297 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2024 | 566 | 0.040 |
Why?
|
| Gait | 1 | 2020 | 146 | 0.040 |
Why?
|
| Child | 1 | 2019 | 26250 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1085 | 0.040 |
Why?
|
| Accelerometry | 1 | 2019 | 66 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1139 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 692 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 739 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3673 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 423 | 0.030 |
Why?
|
| Exercise Test | 1 | 2019 | 243 | 0.030 |
Why?
|
| Fatigue | 1 | 2019 | 199 | 0.030 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2017 | 4 | 0.030 |
Why?
|
| Health Personnel | 1 | 2023 | 549 | 0.030 |
Why?
|
| Hong Kong | 1 | 2016 | 16 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1634 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 459 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 190 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 615 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2567 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 77 | 0.030 |
Why?
|
| Protein Precursors | 2 | 1992 | 147 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2143 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 371 | 0.030 |
Why?
|
| Cadaver | 1 | 2014 | 121 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1356 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 435 | 0.020 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1992 | 20 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 239 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 1003 | 0.020 |
Why?
|
| Osteophyte | 1 | 2011 | 7 | 0.020 |
Why?
|
| Prothrombin | 1 | 1991 | 24 | 0.020 |
Why?
|
| Ligaments | 1 | 2011 | 20 | 0.020 |
Why?
|
| Tendons | 1 | 2011 | 32 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 834 | 0.020 |
Why?
|
| Wrist Joint | 1 | 2011 | 28 | 0.020 |
Why?
|
| Boston | 1 | 2011 | 117 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1492 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1338 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 1799 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 570 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 773 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 453 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 1224 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 1797 | 0.020 |
Why?
|
| DNA | 1 | 1992 | 1442 | 0.020 |
Why?
|
| Biomarkers | 1 | 1991 | 3405 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3412 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 6177 | 0.010 |
Why?
|
| Jejunum | 1 | 1992 | 124 | 0.010 |
Why?
|
| Duodenum | 1 | 1992 | 111 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1992 | 309 | 0.010 |
Why?
|
| Pancreas | 1 | 1992 | 218 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 786 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1991 | 139 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1991 | 174 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2564 | 0.000 |
Why?
|
| Base Sequence | 1 | 1992 | 2782 | 0.000 |
Why?
|
| Gene Expression | 1 | 1992 | 1501 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3615 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1992 | 2567 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1991 | 974 | 0.000 |
Why?
|
| Rats | 1 | 1992 | 3460 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1991 | 901 | 0.000 |
Why?
|
| Animals | 1 | 1992 | 34371 | 0.000 |
Why?
|